UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000048294 |
|---|---|
| Receipt number | R000055036 |
| Scientific Title | The usefulness of the Objective Structured Clinical Examination after clinical training (OSCE) and the development and reliability of a rubric score sheet for use in the OSCE. |
| Date of disclosure of the study information | 2022/07/07 |
| Last modified on | 2026/02/16 16:35:15 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
The usefulness of the Objective Structured Clinical Examination after clinical training (OSCE) and the development and reliability of a rubric score sheet for use in the OSCE.
Acronym
The usefulness of the Objective Structured Clinical Examination after clinical training (OSCE) and the development and reliability of a rubric score sheet for use in the OSCE.
Scientific Title
The usefulness of the Objective Structured Clinical Examination after clinical training (OSCE) and the development and reliability of a rubric score sheet for use in the OSCE.
Scientific Title:Acronym
The usefulness of the Objective Structured Clinical Examination after clinical training (OSCE) and the development and reliability of a rubric score sheet for use in the OSCE.
Region
| Japan |
Condition
Condition
Young healthy adults
Classification by specialty
| Not applicable | Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
The purpose of this study is to examine the usefulness of the Post-Clinical OSCE.
In addition, a rubric table will be developed and its reliability will be examined.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
A rubric table will be developed and its reliability will be examined.
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Self control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Educational,Counseling,Training
Type of intervention
| Other |
Interventions/Control_1
Implementation of OSCE.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 40 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
Students who belong to a speech-language pathologist training school and have completed their clinical training.
Key exclusion criteria
Students who cannot give their consent to cooperate in the research.
Target sample size
200
Research contact person
Name of lead principal investigator
| 1st name | Keigo |
| Middle name | |
| Last name | Matsubara |
Organization
Kumamoto Health Science University
Division name
Faculty of Health Science, Department of Rehabilitation, Division of Speech-Lanuage-Hearing Therapist
Zip code
861-5598
Address
325 Izumi-machi, kita-ku, kumamoto, Japan
TEL
096-275-2111
matubara-ke@kumamoto-hsu.ac.jp
Public contact
Name of contact person
| 1st name | Keigo |
| Middle name | |
| Last name | Matsubara |
Organization
Kumamoto Health Science University
Division name
Faculty of Health Science, Department of Rehabilitation, Division of Speech-Lanuage-Hearing Therapis
Zip code
861-5598
Address
325 Izumi-machi, kita-ku, kumamoto, Japan
TEL
096-275-2111
Homepage URL
matubara-ke@kumamoto-hsu.ac.jp
Sponsor or person
Institute
Kumamoto Health Science University
Institute
Department
Personal name
Funding Source
Organization
Kumamoto Health Science University
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Kumamoto Health Science University
Address
325 Izumi-machi, kita-ku, kumamoto, Japan
Tel
096-275-2111
matubara-ke@kumamoto-hsu.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2022 | Year | 07 | Month | 07 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
No longer recruiting
Date of protocol fixation
| 2022 | Year | 06 | Month | 28 | Day |
Date of IRB
| 2023 | Year | 08 | Month | 29 | Day |
Anticipated trial start date
| 2022 | Year | 06 | Month | 28 | Day |
Last follow-up date
| 2028 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2022 | Year | 07 | Month | 06 | Day |
Last modified on
| 2026 | Year | 02 | Month | 16 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055036
